Design and rationale of Effisayil 1, a Phase II, multicenter, randomized, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis with an acute flare

被引：0

作者：

Choon, Siew Eng ^{[1
]}

Lebwohl, Mark G. ^{[2
]}

Marrakchi, Slaheddine ^{[3
]}

Burden, A. David ^{[4
]}

Tsai, Tsen-Fang ^{[5
,6
]}

Morita, Akimichi ^{[7
]}

Navarini, Alexander A. ^{[8
]}

Deng, Hongjie ^{[9
]}

Thoma, Christian ^{[10
]}

Bachelez, Herve ^{[11
]}

机构：

[1] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Clin Sch Johor Bahru, Selangor Darul Ehsan, Malaysia

[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[3] Hedi Chaker Univ Hosp, Dept Dermatol, Sfax, Tunisia

[4] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Scotland

[5] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan

[6] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[7] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Japan

[8] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland

[9] Boehringer Ingelheim China Investment Co Ltd, Shanghai, Peoples R China

[10] Boehringer Ingelheim Int Gmbh, Biberach, Germany

[11] Univ Paris, Inst Imagine, UMR INSERM U1163, Paris, France

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

26590

引用

页码：AB109 / AB109

页数：1

共 50 条

[21] Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
Kindler, Hedy L.
Karrison, Theodore G.
Gandara, David R.
Lu, Charles
Krug, Lee M.
Stevenson, James P.
Jaenne, Pasi A.
Quinn, David I.
Koczywas, Marianna N.
Brahmer, Julie R.
Albain, Kathy S.
Taber, David A.
Armato, Samuel G., III
Vogelzang, Nicholas J.
Chen, Helen X.
Stadler, Walter M.
Vokes, Everett E.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : 2509 - 2515
[22] Efficacy of naproxen in patients with sciatica: multicenter, randomized, double-blind, placebo-controlled trial
Grovle, Lars
Hasvik, Eivind
Holst, Rene
Saetre, Anders
Brox, Jens Ivar
Mathiassen, Stale
Myhre, Kjersti
Holmgard, Thor Einar
Haugen, Anne Julsrud
PAIN, 2024, 165 (11) : 2606 - 2614
[23] Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial
Heo, Sung Hyuk
Song, Jungbin
Kim, Bum Joon
Kim, Hocheol
Chang, Dae-Il
MEDICINE, 2019, 98 (43)
[24] Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
Petr Ostadal
David Alan
Petr Hajek
Jiri Vejvoda
Martin Mates
Peter Blasko
Josef Veselka
Milan Kvapil
Jiri Kettner
Martin Wiendl
Ondrej Aschermann
Josef Slaby
Eduard Nemecek
Frantisek Holm
Marek Rac
Milan Macek
Jana Cepova
Current Controlled Trials in Cardiovascular Medicine, 2005, 6
[25] Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial) [ISRCTN81331696]
Ostadal, P
Alan, D
Hajek, P
Vejvoda, J
Mates, M
Blasko, P
Veselka, J
Kvapil, M
Kettner, J
Wiendl, M
Aschermann, O
Slaby, J
Nemecek, E
Holm, F
Rac, M
Macek, M
Cepova, J
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2005, 6 (1):
[26] MARVEL: A Randomized Double-Blind, Placebo-Controlled Trial in Patients Undergoing Endovascular Therapy: Study Rationale and Design
Yang, Qingwu
Guo, Changwei
Yue, Chengsong
Yang, Jie
Li, Linyu
Peng, Zhouzhou
Hu, Jinrong
Huang, Jiandi
Song, Jiaxing
Huang, Jiacheng
Kong, Weilin
Yu, Nizhen
Yang, Dahong
Liu, Xiang
Wang, Duolao
Nogueira, Raul G.
Li, Fengli
Nguyen, Thanh N.
Zi, Wenjie
STROKE-VASCULAR AND INTERVENTIONAL NEUROLOGY, 2024, 4 (02):
[27] Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study
Bhushan, M
Burden, AD
McElhone, K
James, R
Vanhoutte, FP
Griffiths, CEM
BRITISH JOURNAL OF DERMATOLOGY, 2001, 145 (04) : 546 - 553
[28] A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)
Li, J.
Xu, R.
Bai, Y.
Xu, J.
Liu, T.
Shen, L.
Wang, L.
Pan, H.
Fan, S.
Hua, Y.
Su, W.
Hugg, C.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S366 - S366
[29] Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial
Yang Hai-zhen
Wang Ke
Jin Hong-zhong
Gao Tian-wen
Xiao Sheng-xiang
Xu Jin-hua
Wang Bao-xi
Zhang Fu-ren
Li Chun-yang
Liu Xiao-ming
Tu Cai-xia
Ji Su-zhen
Shen Yang
Zhu Xue-jun
CHINESE MEDICAL JOURNAL, 2012, 125 (11) : 1845 - 1851
[30] Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)
Gheorghiade, Mihai
Albaghdadi, Mazen
Zannad, Faiez
Fonarow, Gregg C.
Boehm, Michael
Gimpelewicz, Claudio
Botha, Jaco
Moores, Shelley
Lewis, Eldrin F.
Rattunde, Henning
Maggioni, Aldo
EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (01) : 100 - 106

← 1 2 3 4 5 →